Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T16:04:24.379Z.
Calculation as of: 2026-10-06T16:04:24.379Z.
Quote observation: 2026-10-06T16:00:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Market Cap
$14.44M
EV/Assets Ratio
0.33x
TTM Avg
0.58x
3Y Avg
0.58x
5Y Avg
0.58x
Market Cap
$13.97M
EV/Assets Ratio
0.66x
TTM Avg
0.72x
3Y Avg
0.95x
5Y Avg
0.71x
Market Cap
$15.07M
EV/Assets Ratio
1.58x
TTM Avg
2.42x
3Y Avg
1.60x
5Y Avg
1.62x
Market Cap
$13.90M
EV/Assets Ratio
0.03x
TTM Avg
0.07x
3Y Avg
2.59x
5Y Avg
10.30x
Market Cap
$15.25M
EV/Assets Ratio
N/A
TTM Avg
0.20x
3Y Avg
0.20x
5Y Avg
0.23x
Market Cap
$15.30M
EV/Assets Ratio
3.11x
TTM Avg
1.24x
3Y Avg
0.86x
5Y Avg
0.79x
Market Cap
$13.27M
EV/Assets Ratio
0.42x
TTM Avg
2.09x
3Y Avg
11.97x
5Y Avg
8.90x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.51M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | 0.33x | 0.58x | 0.58x | 0.58x |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | 0.66x | 0.72x | 0.95x | 0.71x |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.07M | 1.58x | 2.42x | 1.60x | 1.62x |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.90M | 0.03x | 0.07x | 2.59x | 10.30x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.25M | N/A | 0.20x | 0.20x | 0.23x |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 3.11x | 1.24x | 0.86x | 0.79x |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A | 0.22x | 0.67x | 0.88x |
| Optimi Health Corp. (OPTH)vs › | $13.27M | 0.42x | 2.09x | 11.97x | 8.90x |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | 0.66x | 0.43x | 18.02x | 199.20x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
